Advanced Filters
noise

Pituitary Disorders Clinical Trials

A listing of Pituitary Disorders medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

Found 423 clinical trials
L Lily M Waddell

Preventing Injured Knees From osteoArthritis: Severity Outcomes

This study is being done to find out if metformin is effective at reducing pain by delaying the onset of post-traumatic osteoarthritis (PTOA) after anterior cruciate ligament (ACL) reconstruction. This research study will compare metformin to placebo. The placebo tablet looks exactly like metformin, but contains no metformin. Placebos are …

18 - 45 years of age Both Phase 2
C Claudia Erika Delgado Espinoza, MD, Ph D

Identification and Clinical Relevance of an Oxytocin Deficient State (GLP1 Study)

Oxytocin (OT) is a hypothalamic peptide that enters the peripheral circulation via the posterior pituitary gland. OT plays a key role in regulating appetite, psychopathology, prosocial behavior and sexual function. Hypopituitarism is associated with increased obesity, increased psychopathology, sexual and prosocial dysfunction despite appropriate hormone replacement. A few studies suggest …

18 - 65 years of age Both Phase 4
F For more information at the NIH Clinical Center contact Office of Patient Recruitment (OPR)

Safety and Efficacy of Pegvisomant in Children With Growth Hormone Excess

Background For children with gigantism, too much growth hormone (GH) in the body causes abnormal growth and many other problems. Current treatments often don t work; no medical treatment is approved by FDA. Researchers want to see if the drug pegvisomant can help. Objective To test the role of pegvisomant …

2 - 18 years of age Both Phase 3
F For more information at the NIH Clinical Center contact Office of Patient Recruitment (OPR)

Effect of Vorinostat on ACTH Producing Pituitary Adenomas in Cushing s Disease

Background Cushing s disease is caused by excess ACTH hormone release by a benign tumor of the pituitary gland. It can lead to decreased quality of life and early death. The current best treatment for Cushing s disease is surgery. If surgery does not work or if the tumor returns, …

18 - 100 years of age Both Phase 2
F For more information at the NIH Clinical Center contact Office of Patient Recruitment (OPR)

Feasibility of Endosphenoidal Coil Placement for Imaging of the Sella During Transsphenoidal Surgery

Background Pituitary tumors can cause problems by secreting hormones in the body. They can also problems by growing large and pushing on organs near the pituitary gland. The best treatment for such tumors is to remove them by surgery. But that may be sometimes difficult. Some tumors maybe too small …

18 - 85 years of age Both Phase N/A
g gao jianlin, MD

Application Research on Endoscopic Pseudocapsule-Based Resection for Pituitary Adenomas

Pituitary adenomas are one of the most common primary central nervous system tumors and have an estimated prevalence of 17%. Management of pituitary adenomas involves a multidisciplinary approach that can incorporate surgical, medical, and/or radiation therapies. Over the last two decades, the endoscopic endonasal approach (EEA) has been extensively developed …

18 - 75 years of age Both Phase N/A
J Jonathan Rychen, Dr. med.

Semi-sitting Versus Supine Position in Endoscopic Skull Base Surgery

This study is to prospectively compare the standard supine (control group) and the semi-sitting position (head elevation of 30°; intervention group) in endoscopic endonasal pituitary surgery.

18 - 100 years of age Both Phase N/A
S Stine L Fougner, MD PhD

Dopamine Agonist Treatment of Non-functioning Pituitary Adenomas

Due to lack of hormone overproduction in non-functioning pituitary adenomas (NFPAs), only the symptomatic adenomas or large adenomas with proven growth and risk for symptoms in near future will undergo pituitary surgery. The remaining adenomas are monitored regularly. Operation of these large adenomas will rarely remove all tumour tissue, and …

18 - 75 years of age Both Phase 3
J Jung Hee Kim, M.D

Comparison of Treatment Outcome of Cabergoline According to Target Prolactin Levels in Patients With Prolactinoma

The aim of this study is to investigate whether inhibition of serum prolactin levels below normal range during cabergoline administration may reduce the recurrence rate after drug withdrawal in patients with prolactinomas.

19 - 100 years of age Both Phase N/A
N Nathalie Compté, PhD

Asymptomatic Bacteriuria, Hyponatremia and Geri-atric Syndrome

The population is aging. Aged people are more prown to develop frailty. The causes of frailty are multifactorial and are being investigated in research settings. Cardiovascular diseases, inflammaging and changes in microbiota have been associated with frailty and geriatric syndrome. The prevalence of asymptomatic bacteriuria and SIADH-related hyponatremia is also …

70 - 100 years of age Both Phase N/A

Rewrite in simple language using AI